Comparison of Diagnostic Accuracy of Tuberculosis Spondylitis between Genexpert and Histopathological Examination
Abstract
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. Spinal TB is associated with poor functional outcomes. Histopathological examination requires a long waiting times to obtain the results thus impractical for screening and may delay diagnosis. GeneXpert offers rapid tests for prompt screening and diagnosis. This study aimed to assess the diagnostic accuracy of GeneXpert in patients with spinal TB when compared to the histopathology test as the gold standard. This study was performed on patients in the Spine Clinic of the Department of Orthopedic and Traumatology, Dr. Hasan Sadikin General Hospital Bandung who were diagnosed with spinal TB during the period of May 2019–May 2020. Blood samples were collected from the patients and tested using GeneXpert and histopathological assessment. Results demonstrated 34 patients with a positive result and 6 patients with negative results on both diagnostic methods. Twenty nine out of 40 patients (72.5%) had rifampin-sensitive TB. Diagnostic accuracy of GeneXpert, when compared to histopathological examination, is represented by the sensitivity of 88.2%, specificity of 33.3%, positive predictive value of 88.2%, and negative predictive value of 33.3%. High sensitivity results forpatients with spinal TB on GeneXpert suggests that the test is appropriate to be used as a screening method and as a high-yield rapid diagnostic test for patients suspected for spinal TB.
Keywords
Full Text:
PDFReferences
Pellisé F. Tuberculosis and Pott’s disease, still very relevant health problems. Eur Spine J. 2013;22(Suppl 4): 527–8.
Millet JP, Moreno A, Fina L, Baño L Del, Orcau A, De Olalla PG, et al. Factors that influence current tuberculosis epidemiology. Eur Spine J. 2013;22 Suppl 4(Suppl 4):539–48.
WHO (Global Tuberculosis Programme). Global tuberculosis report 2020. Geneva: World Health Organization; 2020. p. 232.
Paton NI, Borand L, Benedicto J, Kyi MM, Mahmud AM, Norazmi MN, et al. Diagnosis and management of latent tuberculosis infection in Asia: Review of current status and challenges. Int J Infect Dis. 2019;87:21–9.
Merza M, Farnia P, Anoosheh S, Varahram M, Kazampour M, Pajand O, et al. The NRAMPI, VDR and TNF-alpha gene polymorphisms in Iranian tuberculosis patients: the study on host susceptibility. Brazilian J Infect Dis. 2009;13(4):252–6.
Nataprawira H, Rahim A, Dewi M, Ismail Y. Comparation between operative and conservative therapy of spondylitis tuberculosis in Hasan Sadikin Hospital Bandung. J Indones Med Assoc. 2011;60(7):6.
Rasouli MR, Mirkoohi M, Vaccaro AR, Yarandi KK, Rahimi-Movaghar V. Spinal tuberculosis: diagnosis and management. Asian Spine J. 2012;6(4):294–308.
Agrawal M. Comparative study of genexpert with ZN stain and culture in samples of suspected pulmonary tuberculosis. J Clin Diagnostic Res. 2016;10(5):DC09–12.
Le Palud P, Cattoir V, Malbruny B, Magnier R, Campbell K, Oulkhouir Y, et al. Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis. BMC Pulm Med. 2014;14(1):137.
Solanki AM, Basu S, Biswas A, Roy S, Banta A. Sensitivity and specificity of gene Xpert in the diagnosis of spinal tuberculosis: a prospective controlled clinical study. Glob Spine J. 2020;10(5):553–8.
Scott LE, Beylis N, Nicol M, Nkuna G, Molapo S, Berrie L, et al. Diagnostic accuracy of Xpert MTB/RIF for extrapulmonary tuberculosis specimens: establishing a laboratory testing algorithm for South Africa. J Clin Microbiol. 2014;52(6):1818–23.
Held M, Laubscher M, Zar HJ, Dunn RN. GeneXpert polymerase chain reaction for spinal tuberculosis. Bone Joint J. 2014;96-B(10):1366–9.
DOI: https://doi.org/10.15395/mkb.v53n1.2234
Article Metrics
Abstract view : 772 timesPDF - 505 times
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
MKB is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
View My Stats